PURPOSE: Spontaneous resolution of vitreomacular traction syndrome in diabetic patients is a rare phenomenon that has been poorly described in the literature. METHODS: Case presentation. RESULTS: The authors present a case of spontaneous resolution of vitreomacular traction following intravitreal administration of ranibizumab. CONCLUSIONS: In patients with vitreomacular traction syndrome and diabetic macular edema, the combination of the possible vitreous liquefaction and mechanical increase of vitreous volume caused by an intravitreal injection with a degree of reduction in retinal thickness caused by the effect of vascular endothelial growth factor inhibition could play a role in the resolution of vitreomacular traction.
PURPOSE: Spontaneous resolution of vitreomacular traction syndrome in diabeticpatients is a rare phenomenon that has been poorly described in the literature. METHODS: Case presentation. RESULTS: The authors present a case of spontaneous resolution of vitreomacular traction following intravitreal administration of ranibizumab. CONCLUSIONS: In patients with vitreomacular traction syndrome and diabetic macular edema, the combination of the possible vitreous liquefaction and mechanical increase of vitreous volume caused by an intravitreal injection with a degree of reduction in retinal thickness caused by the effect of vascular endothelial growth factor inhibition could play a role in the resolution of vitreomacular traction.